[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100648356":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":21,"locations":27,"responsibleParty":43,"collaborators":45,"id":49,"slug":50,"hasResults":51,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":20,"eligibilityCriteria":54,"healthyVolunteers":55,"sex":56,"minAge":20,"maxAge":20,"enrollmentInfo":57,"targetDuration":20,"studyType":60,"phases":61,"briefSummary":63,"conditions":64,"keywords":68,"overallStatus":73,"whyStopped":20,"lastUpdateSubmitDate":74,"lastUpdatePostDateStruct":75,"startDateStruct":78,"completionDateStruct":80,"leadSponsor":82,"locationsCount":83},{"fullName":5,"class":6},"Dream Video LLC","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"P1821 #1","EXPERIMENTAL","P1821 interventions are administered once daily over a period of fourteen days.",[13],"Device: P1821",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","P1821","The P1821 intervention is distinguished by its independence from pharmaceutical agents and electronic devices. Its foundational mechanism is predicated exclusively on the physiological principles of muscle resistance training, thereby offering a non-pharmacological and non-invasive therapeutic approach.",[9],null,[22],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},"Matthew Quitto II","CONTACT","917-342-2895","dream@dreamholdingsllc.com",[28],{"facility":29,"status":20,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"N\u002FA - Remote Study","Naples","Florida","34119","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-81.79596,26.14234,{"lat":39,"lon":38},[42],{"name":23,"role":24,"phone":25,"phoneExt":20,"email":26},{"type":44,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR",[46],{"name":47,"class":48},"Dream Holdings Research","UNKNOWN","100648356","effectivity-of-p1821-a-novel-tongue-strengthening-and-endurance-enhancing-speech-flow-exercise-100648356",false,"NCT07719582","Effectivity of P1821, a Novel Tongue Strengthening and Endurance Enhancing Speech Flow Exercise","Inclusion Criteria:\n\n* Can read and write\n* Willing and able to follow the requirements of the protocol\n\nExclusion Criteria:\n\n* Previously seen and treated by speech and language pathologist for dysphagia or dysarthria for non-head and neck cancer causes\n* Medical instability, restlessness, or other factors that would compromise data acquisition",true,"ALL",{"count":58,"type":59},100,"ESTIMATED","INTERVENTIONAL",[62],"NA","The P1821 initiative constitutes an innovative intervention specifically engineered to enhance tongue muscular strength and endurance. The primary objective of this research study is to ascertain whether the integration of a proactive tongue strengthening exercise regimen, utilizing a Non-Significant Risk (NSR) Device, contributes to an observable improvement in speech fluency.",[65,66,67],"Ankyloglossia","Impairment of Speech","Slurred Speech",[69,70,71,72],"Tongue-strengthening self-exercises (TSsE)","Tongue strength","Home-based exercise","Self-exercise","NOT_YET_RECRUITING","2026-07-18",{"date":76,"type":77},"2026-07-22","ACTUAL",{"date":79,"type":59},"2028-01-01",{"date":81,"type":59},"2030-01-01",{"name":5,"class":6},1]